特発性肺線維症（IPF）は、肺組織の瘢痕化を特徴とする慢性進行性肺疾患で、酸素供給の低下と重篤な呼吸困難を引き起こします。原因不明のIPFは、主に70～75歳の人に発症しますが、50歳未満ではまれです。米国国立衛生研究所によると、世界全体では10万人あたり13～20人が罹患しており、アメリカだけでも約10万人が罹患し、年間3～4万人が新たに診断されています。IPF治療薬市場は、ニンテダニブ、ピルフェニドンといった主要薬剤に加え、「その他」における新規候補薬など、疾患の進行を遅らせ、症状を管理し、生活の質を向上させる治療法に重点を置いています。この業界は、特に承認されている薬剤が2種類しかない中国などの市場では、アンメット臨床ニーズが高いことが特徴であり、大きなイノベーションと投資を促進しています。 2019年から2023年にかけて、中国のIPF治療市場は2億3,000万米ドル（146億人民元）から7億9,400万米ドル（504億人民元）に成長し、2028年までに14億2,000万米ドル（903億人民元）に達すると予測されており、この衰弱性疾患への対処が世界的に緊急に求められていることを反映しています。
世界の特発性肺線維症治療薬市場は、2025年には42億～48億米ドルに達すると推定されており、2030年までの年平均成長率（CAGR）は6%～8%と予測され、58億～65億米ドルに達する可能性があります。この成長は、罹患率の上昇、人口の高齢化、そして抗線維化療法の進歩によって推進されています。
目次
Table of Contents
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Idiopathic Pulmonary Fibrosis Drug Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Idiopathic Pulmonary Fibrosis Drug Market in North America (2020-2030)
8.1 Idiopathic Pulmonary Fibrosis Drug Market Size
8.2 Idiopathic Pulmonary Fibrosis Drug Market by End Use
8.3 Competition by Players/Suppliers
8.4 Idiopathic Pulmonary Fibrosis Drug Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Idiopathic Pulmonary Fibrosis Drug Market in South America (2020-2030)
9.1 Idiopathic Pulmonary Fibrosis Drug Market Size
9.2 Idiopathic Pulmonary Fibrosis Drug Market by End Use
9.3 Competition by Players/Suppliers
9.4 Idiopathic Pulmonary Fibrosis Drug Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Idiopathic Pulmonary Fibrosis Drug Market in Asia & Pacific (2020-2030)
10.1 Idiopathic Pulmonary Fibrosis Drug Market Size
10.2 Idiopathic Pulmonary Fibrosis Drug Market by End Use
10.3 Competition by Players/Suppliers
10.4 Idiopathic Pulmonary Fibrosis Drug Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Idiopathic Pulmonary Fibrosis Drug Market in Europe (2020-2030)
11.1 Idiopathic Pulmonary Fibrosis Drug Market Size
11.2 Idiopathic Pulmonary Fibrosis Drug Market by End Use
11.3 Competition by Players/Suppliers
11.4 Idiopathic Pulmonary Fibrosis Drug Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Idiopathic Pulmonary Fibrosis Drug Market in MEA (2020-2030)
12.1 Idiopathic Pulmonary Fibrosis Drug Market Size
12.2 Idiopathic Pulmonary Fibrosis Drug Market by End Use
12.3 Competition by Players/Suppliers
12.4 Idiopathic Pulmonary Fibrosis Drug Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Idiopathic Pulmonary Fibrosis Drug Market (2020-2025)
13.1 Idiopathic Pulmonary Fibrosis Drug Market Size
13.2 Idiopathic Pulmonary Fibrosis Drug Market by End Use
13.3 Competition by Players/Suppliers
13.4 Idiopathic Pulmonary Fibrosis Drug Market Size by Type
Chapter 14 Global Idiopathic Pulmonary Fibrosis Drug Market Forecast (2025-2030)
14.1 Idiopathic Pulmonary Fibrosis Drug Market Size Forecast
14.2 Idiopathic Pulmonary Fibrosis Drug Application Forecast
14.3 Competition by Players/Suppliers
14.4 Idiopathic Pulmonary Fibrosis Drug Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 AstraZeneca PLC
15.1.1 Company Profile
15.1.2 Main Business and Idiopathic Pulmonary Fibrosis Drug Information
15.1.3 SWOT Analysis of AstraZeneca PLC
15.1.4 AstraZeneca PLC Idiopathic Pulmonary Fibrosis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.2 Boehringer Ingelheim
15.2.1 Company Profile
15.2.2 Main Business and Idiopathic Pulmonary Fibrosis Drug Information
15.2.3 SWOT Analysis of Boehringer Ingelheim
15.2.4 Boehringer Ingelheim Idiopathic Pulmonary Fibrosis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.3 Bristol Myers Squibb Co.
15.3.1 Company Profile
15.3.2 Main Business and Idiopathic Pulmonary Fibrosis Drug Information
15.3.3 SWOT Analysis of Bristol Myers Squibb Co.
15.3.4 Bristol Myers Squibb Co. Idiopathic Pulmonary Fibrosis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.4 Novartis AG
15.4.1 Company Profile
15.4.2 Main Business and Idiopathic Pulmonary Fibrosis Drug Information
15.4.3 SWOT Analysis of Novartis AG
15.4.4 Novartis AG Idiopathic Pulmonary Fibrosis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.5 Avalyn Pharma Inc.
15.5.1 Company Profile
15.5.2 Main Business and Idiopathic Pulmonary Fibrosis Drug Information
15.5.3 SWOT Analysis of Avalyn Pharma Inc.
15.5.4 Avalyn Pharma Inc. Idiopathic Pulmonary Fibrosis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.6 Bellerophon Therapeutics Inc.
15.6.1 Company Profile
15.6.2 Main Business and Idiopathic Pulmonary Fibrosis Drug Information
15.6.3 SWOT Analysis of Bellerophon Therapeutics Inc.
15.6.4 Bellerophon Therapeutics Inc. Idiopathic Pulmonary Fibrosis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.7 Endeavor Biomedicines Inc.
15.7.1 Company Profile
15.7.2 Main Business and Idiopathic Pulmonary Fibrosis Drug Information
15.7.3 SWOT Analysis of Endeavor Biomedicines Inc.
15.7.4 Endeavor Biomedicines Inc. Idiopathic Pulmonary Fibrosis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.8 Horizon Therapeutics Public Limited Company
15.8.1 Company Profile
15.8.2 Main Business and Idiopathic Pulmonary Fibrosis Drug Information
15.8.3 SWOT Analysis of Horizon Therapeutics Public Limited Company
15.8.4 Horizon Therapeutics Public Limited Company Idiopathic Pulmonary Fibrosis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.9 Pliant Therapeutics Inc.
15.9.1 Company Profile
15.9.2 Main Business and Idiopathic Pulmonary Fibrosis Drug Information
15.9.3 SWOT Analysis of Pliant Therapeutics Inc.
15.9.4 Pliant Therapeutics Inc. Idiopathic Pulmonary Fibrosis Drug Revenue, Gross Margin and Market Share (2020-2025)
15.10 Suzhou Zelgen Biopharmaceuticals Co. Ltd.
15.10.1 Company Profile
15.10.2 Main Business and Idiopathic Pulmonary Fibrosis Drug Information
15.10.3 SWOT Analysis of Suzhou Zelgen Biopharmaceuticals Co. Ltd.
15.10.4 Suzhou Zelgen Biopharmaceuticals Co. Ltd. Idiopathic Pulmonary Fibrosis Drug Revenue, Gross Margin and Market Share (2020-2025)
Please ask for sample pages for full companies list
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Idiopathic Pulmonary Fibrosis Drug Report
Table Data Sources of Idiopathic Pulmonary Fibrosis Drug Report
Table Major Assumptions of Idiopathic Pulmonary Fibrosis Drug Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Idiopathic Pulmonary Fibrosis Drug Picture
Table Idiopathic Pulmonary Fibrosis Drug Classification
Table Idiopathic Pulmonary Fibrosis Drug Applications
Table Drivers of Idiopathic Pulmonary Fibrosis Drug Market
Table Restraints of Idiopathic Pulmonary Fibrosis Drug Market
Table Opportunities of Idiopathic Pulmonary Fibrosis Drug Market
Table Threats of Idiopathic Pulmonary Fibrosis Drug Market
Table Covid-19 Impact For Idiopathic Pulmonary Fibrosis Drug Market
Table Raw Materials Suppliers
Table Different Production Methods of Idiopathic Pulmonary Fibrosis Drug
Table Cost Structure Analysis of Idiopathic Pulmonary Fibrosis Drug
Table Key End Users
Table Latest News of Idiopathic Pulmonary Fibrosis Drug Market
Table Merger and Acquisition
Table Planned/Future Project of Idiopathic Pulmonary Fibrosis Drug Market
Table Policy of Idiopathic Pulmonary Fibrosis Drug Market
Table 2020-2030 North America Idiopathic Pulmonary Fibrosis Drug Market Size
Figure 2020-2030 North America Idiopathic Pulmonary Fibrosis Drug Market Size and CAGR
Table 2020-2030 North America Idiopathic Pulmonary Fibrosis Drug Market Size by Application
Table 2020-2025 North America Idiopathic Pulmonary Fibrosis Drug Key Players Revenue
Table 2020-2025 North America Idiopathic Pulmonary Fibrosis Drug Key Players Market Share
Table 2020-2030 North America Idiopathic Pulmonary Fibrosis Drug Market Size by Type
Table 2020-2030 United States Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2030 Canada Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2030 Mexico Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2030 South America Idiopathic Pulmonary Fibrosis Drug Market Size
Figure 2020-2030 South America Idiopathic Pulmonary Fibrosis Drug Market Size and CAGR
Table 2020-2030 South America Idiopathic Pulmonary Fibrosis Drug Market Size by Application
Table 2020-2025 South America Idiopathic Pulmonary Fibrosis Drug Key Players Revenue
Table 2020-2025 South America Idiopathic Pulmonary Fibrosis Drug Key Players Market Share
Table 2020-2030 South America Idiopathic Pulmonary Fibrosis Drug Market Size by Type
Table 2020-2030 Brazil Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2030 Argentina Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2030 Chile Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2030 Peru Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2030 Asia & Pacific Idiopathic Pulmonary Fibrosis Drug Market Size
Figure 2020-2030 Asia & Pacific Idiopathic Pulmonary Fibrosis Drug Market Size and CAGR
Table 2020-2030 Asia & Pacific Idiopathic Pulmonary Fibrosis Drug Market Size by Application
Table 2020-2025 Asia & Pacific Idiopathic Pulmonary Fibrosis Drug Key Players Revenue
Table 2020-2025 Asia & Pacific Idiopathic Pulmonary Fibrosis Drug Key Players Market Share
Table 2020-2030 Asia & Pacific Idiopathic Pulmonary Fibrosis Drug Market Size by Type
Table 2020-2030 China Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2030 India Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2030 Japan Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2030 South Korea Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2030 Southeast Asia Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2030 Australia Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2030 Europe Idiopathic Pulmonary Fibrosis Drug Market Size
Figure 2020-2030 Europe Idiopathic Pulmonary Fibrosis Drug Market Size and CAGR
Table 2020-2030 Europe Idiopathic Pulmonary Fibrosis Drug Market Size by Application
Table 2020-2025 Europe Idiopathic Pulmonary Fibrosis Drug Key Players Revenue
Table 2020-2025 Europe Idiopathic Pulmonary Fibrosis Drug Key Players Market Share
Table 2020-2030 Europe Idiopathic Pulmonary Fibrosis Drug Market Size by Type
Table 2020-2030 Germany Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2030 France Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2030 United Kingdom Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2030 Italy Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2030 Spain Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2030 Belgium Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2030 Netherlands Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2030 Austria Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2030 Poland Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2030 Russia Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2030 MEA Idiopathic Pulmonary Fibrosis Drug Market Size
Figure 2020-2030 MEA Idiopathic Pulmonary Fibrosis Drug Market Size and CAGR
Table 2020-2030 MEA Idiopathic Pulmonary Fibrosis Drug Market Size by Application
Table 2020-2025 MEA Idiopathic Pulmonary Fibrosis Drug Key Players Revenue
Table 2020-2025 MEA Idiopathic Pulmonary Fibrosis Drug Key Players Market Share
Table 2020-2030 MEA Idiopathic Pulmonary Fibrosis Drug Market Size by Type
Table 2020-2030 Egypt Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2030 Israel Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2030 South Africa Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2030 Gulf Cooperation Council Countries Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2030 Turkey Idiopathic Pulmonary Fibrosis Drug Market Size
Table 2020-2025 Global Idiopathic Pulmonary Fibrosis Drug Market Size by Region
Table 2020-2025 Global Idiopathic Pulmonary Fibrosis Drug Market Size Share by Region
Table 2020-2025 Global Idiopathic Pulmonary Fibrosis Drug Market Size by Application
Table 2020-2025 Global Idiopathic Pulmonary Fibrosis Drug Market Share by Application
Table 2020-2025 Global Idiopathic Pulmonary Fibrosis Drug Key Vendors Revenue
Figure 2020-2025 Global Idiopathic Pulmonary Fibrosis Drug Market Size and Growth Rate
Table 2020-2025 Global Idiopathic Pulmonary Fibrosis Drug Key Vendors Market Share
Table 2020-2025 Global Idiopathic Pulmonary Fibrosis Drug Market Size by Type
Table 2020-2025 Global Idiopathic Pulmonary Fibrosis Drug Market Share by Type
Table 2025-2030 Global Idiopathic Pulmonary Fibrosis Drug Market Size by Region
Table 2025-2030 Global Idiopathic Pulmonary Fibrosis Drug Market Size Share by Region
Table 2025-2030 Global Idiopathic Pulmonary Fibrosis Drug Market Size by Application
Table 2025-2030 Global Idiopathic Pulmonary Fibrosis Drug Market Share by Application
Table 2025-2030 Global Idiopathic Pulmonary Fibrosis Drug Key Vendors Revenue
Figure 2025-2030 Global Idiopathic Pulmonary Fibrosis Drug Market Size and Growth Rate
Table 2025-2030 Global Idiopathic Pulmonary Fibrosis Drug Key Vendors Market Share
Table 2025-2030 Global Idiopathic Pulmonary Fibrosis Drug Market Size by Type
Table 2025-2030 Idiopathic Pulmonary Fibrosis Drug Global Market Share by Type
